Journal of Chest Surgery

  • 제45권5호
  • /
  • Pages.275-286
  • /
  • 2012
  • /
  • 2765-1606(pISSN)
  • /
  • 2765-1614(eISSN)
대한심장혈관흉부외과학회 (The Korean Society for Thoracic and Cardiovascular Surgery)
권호 표지
DOI QR코드

DOI QR Code

Conduits for Coronary Bypass: Vein Grafts

  • Barner, Hendrick B. (Division of Cardiothoracic Surgery, St. Louis University Hospital) ;
  • Farkas, Emily A. (Division of Cardiothoracic Surgery, St. Louis University Hospital)
  • 투고 : 2012.07.11
  • 심사 : 2012.08.17
  • 발행 : 2012.10.05
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The saphenous vein has been the principal conduit for coronary bypass grafting from the beginning, circa 1970. This report briefly traces this history and concomitantly presents one surgeons experience and personal views on use of the vein graft. As such it is not exhaustive but meant to be practical with a modest number of references. The focus is that of providing guidance and perspective which may be at variance with that of others and recognizing that there may be many ways to accomplish the task at hand. Hopefully the surgeon in training/early career may find this instructive on the journey to surgical maturity.

키워드

참고문헌

  1. Sabiston DC Jr. Direct surgical management of congenital and acquired lesions of the coronary circulation. Prog Cardiovasc Dis 1963;6:299-316. https://doi.org/10.1016/S0033-0620(63)80040-7
  2. Garrett HE, Dennis EW, DeBakey ME. Aortocoronary bypass with saphenous vein graft: seven-year follow-up. JAMA 1973;223:792-794. https://doi.org/10.1001/jama.1973.03220070046012
  3. Favaloro RG. Saphenous vein graft in the surgical treatment of coronary artery disease: operative technique. J Thorac Cardiovasc Surg 1969;58:178-185.
  4. Johnson WD, Flemma RJ, Lepley D Jr, Ellison EH. Extended treatment of severe coronary artery disease: a total surgical approach. Ann Surg 1969;170:460-470. https://doi.org/10.1097/00000658-196909010-00014
  5. Bartley TD, Bigelow JC, Page US. Aortocoronary bypass grafting with multiple sequential anastomoses to a single vein. Arch Surg 1972;105:915-917. https://doi.org/10.1001/archsurg.1972.04180120092017
  6. Stoney WS, Alford WC Jr, Burrus GR, Glassford DM Jr, Petracek MR, Thomas CS Jr. The fate of arm veins used for aorta-coronary bypass grafts. J Thorac Cardiovasc Surg 1984;88:522-526.
  7. Kraeger RR, Lagos JA, Barner HB. Long term evaluation of allogenic veins as arterial grafts. Vasc Surg 1976;10:121-127. https://doi.org/10.1177/153857447601000208
  8. Virmani R, Atkinson JB, Forman MB. Aortocoronary saphenous vein bypass grafts. Cardiovasc Clin 1988;18:41-62.
  9. Souza DS, Dashwood MR, Tsui JC, et al. Improved patency in vein grafts harvested with surrounding tissue: results of a randomized study using three harvesting techniques. Ann Thorac Surg 2002;73:1189-1195. https://doi.org/10.1016/S0003-4975(02)03425-2
  10. Lopes RD, Hafley GE, Allen KB, et al. Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med 2009;361:235-244. https://doi.org/10.1056/NEJMoa0900708
  11. Zenati MA, Shroyer AL, Collins JF, et al. Impact of endoscopic versus open saphenous vein harvest technique on late coronary artery bypass grafting patient outcomes in the ROOBY (Randomized On/Off Bypass) Trial. J Thorac Cardiovasc Surg 2011;141:338-344. https://doi.org/10.1016/j.jtcvs.2010.10.004
  12. Wilbring M, Tugtekin SM, Zatschler B, et al. Even shorttime storage in physiological saline solution impairs endothelial vascular function of saphenous vein grafts. Eur J Cardiothorac Surg 2011;40:811-815.
  13. Wilbring M, Ebner A, Schoenemann K, et al. Heparizized blood is superior to isotonic sodium-chloride-solution for intraoperative storage of saphenous veins. Ann thorac Surg 2012 in press.
  14. Angelini GD, Breckenridge IM, Williams HM, Newby AC. A surgical preparative technique for coronary bypass grafts of human saphenous vein which preserves medial and endothelial functional integrity. J Thorac Cardiovasc Surg 1987; 94:393-398.
  15. Thatte HS, Khuri SF. The coronary artery bypass conduit: I. Intraoperative endothelial injury and its implication on graft patency. Ann Thorac Surg 2001;72:S2245-S2252. https://doi.org/10.1016/S0003-4975(01)03272-6
  16. Broeders MA, Doevendans PA, Maessen JG, et al. The human internal thoracic artery releases more nitric oxide in response to vascular endothelial growth factor than the human saphenous vein. J Thorac Cardiovasc Surg 2001;122: 305-309. https://doi.org/10.1067/mtc.2001.113602
  17. Thiene G, Miazzi P, Valsecchi M, et al. Histological survey of the saphenous vein before its use as autologous aortocoronary bypass graft. Thorax 1980;35:519-522. https://doi.org/10.1136/thx.35.7.519
  18. Milroy CM, Scott DJ, Beard JD, Horrocks M, Bradfield JW. Histological appearances of the long saphenous vein. J Pathol 1989;159:311-316. https://doi.org/10.1002/path.1711590408
  19. Dobrin PB, Littooy FN, Golan J, Blakeman B, Fareed J. Mechanical and histologic changes in canine vein grafts. J Surg Res 1988;44:259-265. https://doi.org/10.1016/0022-4804(88)90056-X
  20. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376. https://doi.org/10.1038/288373a0
  21. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-142.
  22. Vanhoutte PM. Other endothelium-derived vasoactive factors. Circulation 1993;87(Suppl 5):V9-V17.
  23. Davies MG, Kim JH, Dalen H, Makhoul RG, Svendsen E, Hagen PO. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine. Surgery 1994; 116:557-568.
  24. Buonassisi V. Sulfated mucopolysaccharide synthesis and secretion in endothelial cell cultures. Exp Cell Res 1973;76: 363-368. https://doi.org/10.1016/0014-4827(73)90388-1
  25. Chan V, Chan TK. Antithrombin III in fresh and cultured human endothelial cells: a natural anticoagulant from the vascular endothelium. Thromb Res 1979;15:209-213. https://doi.org/10.1016/0049-3848(79)90066-5
  26. Lawrie GM, Weilbacher DE, Henry PD. Endothelium-dependent relaxation in human saphenous vein grafts. Effects of preparation and clinicopathologic correlations. J Thorac Cardiovasc Surg 1990;100:612-620.
  27. Bush HL Jr, McCabe ME, Nabseth DC. Functional injury of vein graft endothelium: role of hypothermia and distention. Arch Surg 1984;119:770-774. https://doi.org/10.1001/archsurg.1984.01390190014003
  28. Angelini GD, Christie MI, Bryan AJ, Lewis MJ. Surgical preparation impairs release of endothelium-derived relaxing factor from human saphenous vein. Ann Thorac Surg 1989; 48:417-420. https://doi.org/10.1016/S0003-4975(10)62869-X
  29. Cambria RP, Megerman J, Abbott WM. Endothelial preservation in reversed and in situ autogenous vein grafts: a quantitative experimental study. Ann Surg 1985;202:50-55. https://doi.org/10.1097/00000658-198507000-00007
  30. Barner HB. Techniques of myocardial revascularization. In: Edmunds LH Jr, editor. Cardiac Surgery in the Adult. New York: McGraw-Hill; 1997. p. 481-534.
  31. Marco JD, Barner HB, Kaiser GC, Codd JE, Mudd JG, Willman V. Operative flow measurements and coronary bypass graft patency. J Thorac Cardiovasc Surg 1976;71:545-547.
  32. Walpoth BH, Bosshard A, Genyk I, et al. Transit-time flow measurement for detection of early graft failure during myocardial revascularization. Ann Thorac Surg 1998;66:1097-1100 https://doi.org/10.1016/S0003-4975(98)00653-5
  33. Kim KB, Kang CH, Lim C. Prediction of graft flow impairment by intraoperative transit time flow measurement in off-pump coronary artery bypass using arterial grafts. Ann Thorac Surg 2005;80:594-598. https://doi.org/10.1016/j.athoracsur.2005.02.047
  34. Leong DK, Ashok V, Nishkantha A, Shan YH, Sim EK. Transit-time flow measurement is essential in coronary artery bypass grafting. Ann Thorac Surg 2005;79:854-857. https://doi.org/10.1016/j.athoracsur.2004.06.010
  35. Grondin CM, Castonguay YR, Lesperance J, Bourassa MG, Campeau L, Grondin P. Attrition rate of aorta-to-coronary artery saphenous vein grafts after one year: a study in a consecutive series of 96 patients. Ann Thorac Surg 1972;14: 223-231. https://doi.org/10.1016/S0003-4975(10)65225-3
  36. Barner HB, Standeven JW, Reese J. Twelve-year experience with internal mammary artery for coronary artery bypass. J Thorac Cardiovasc Surg 1985;90:668-675.
  37. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996;28:616-626. https://doi.org/10.1016/0735-1097(96)00206-9
  38. Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg 2004; 77:93-101. https://doi.org/10.1016/S0003-4975(03)01331-6
  39. Dion R, Glineur D, Derouck D, et al. Complementary saphenous grafting: long-term follow-up. J Thorac Cardiovasc Surg 2001;122:296-304. https://doi.org/10.1067/mtc.2001.115419
  40. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 1997;336:153-162. https://doi.org/10.1056/NEJM199701163360301
  41. Campeau L, Hunninghake DB, Knatterud GL, et al. Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators. Circulation 1999;99:3241-3247. https://doi.org/10.1161/01.CIR.99.25.3241
  42. Christenson JT, Simonet F, Schmuziger M. Sequential vein bypass grafting: tactics and long-term results. Cardiovasc Surg 1998;6:389-397. https://doi.org/10.1016/S0967-2109(98)00024-6
  43. Kieser TM, FitzGibbon GM, Keon WJ. Sequential coronary bypass grafts: long-term follow-up. J Thorac Cardiovasc Surg 1986;91:767-772.
  44. Hong YJ, Mintz GS, Kim SW, et al. Disease progression in nonintervened saphenous vein graft segments a serial intravascular ultrasound analysis. J Am Coll Cardiol 2009;53: 1257-1264. https://doi.org/10.1016/j.jacc.2008.12.048
  45. Mendelsohn FO, Foster GP, Palacios IF, Weyman AE, Weissman NJ. In vivo assessment by intravascular ultrasound of enlargement in saphenous vein bypass grafts. Am J Cardiol 1995;76:1066-1069. https://doi.org/10.1016/S0002-9149(99)80299-9
  46. Ge J, Liu F, Bhate R, et al. Does remodeling occur in the diseased human saphenous vein bypass grafts? An intravascular ultrasound study. Int J Card Imaging 1999;15:295-300. https://doi.org/10.1023/A:1006125205217
  47. Galvin IF. New shapes and sizes: a T-tube coronary conduit. Ann Thorac Surg 1993;56:1184. https://doi.org/10.1016/0003-4975(95)90048-9

피인용 문헌

  1. Conduits for Coronary Bypass: Arteries Other Than the Internal Thoracic Artery's vol.46, pp.3, 2012, https://doi.org/10.5090/kjtcs.2013.46.3.165
  2. Small Diameter Xenogeneic Extracellular Matrix Scaffolds for Vascular Applications vol.26, pp.1, 2012, https://doi.org/10.1089/ten.teb.2019.0229
  3. Saphenous vein graft disease, pathophysiology, prevention, and treatment. A review of the literature vol.35, pp.6, 2012, https://doi.org/10.1111/jocs.14542
  4. Effective decellularisation of human saphenous veins for biocompatible arterial tissue engineering applications: Bench optimisation and feasibility in vivo testing vol.12, pp.None, 2012, https://doi.org/10.1177/2041731420987529